SCHEMBL30262006

SCHEMBL30262006

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 11/20 0.52
▸ CALCR P30988 4/20 0.51
▸ CRHR1 P34998 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ HCRTR1 O43613 1/20 0.50
▸ HCRTR2 O43614 1/20 0.50
▸ GRIN2D O15399 1/20 0.49
▸ GRIN3B O60391 1/20 0.49
▸ GRIN1 Q05586 1/20 0.49
▸ GRIN2A Q12879 1/20 0.49
▸ GRIN2B Q13224 1/20 0.49
▸ GRIN2C Q14957 1/20 0.49
▸ GRIN3A Q8TCU5 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625325 0.96 CALCR (0.55) GLP1RCALCRCRHR1CRHR2GRIN2D
SCHEMBL30524353 0.91 GLP1R (0.48) GLP1RCALCRRXFP1HCRTR1HCRTR2
SCHEMBL30524358 0.89 GLP1R (0.62) GLP1RCALCRCRHR1CRHR2
SCHEMBL29796964 0.89 GLP1R (0.55) GLP1RCALCRCRHR1CRHR2
Magainin I SCHEMBL29392863 0.89 CALCR (0.59) GLP1RCALCRCRHR1CRHR2RXFP1
SCHEMBL29633610 0.88 CALCR (0.63) GLP1RCALCRCRHR1CRHR2RXFP1
Magainin 2 SCHEMBL29357968 0.88 CALCR (0.63) GLP1RCALCRCRHR1CRHR2RXFP1
SCHEMBL29797050 0.88 GLP1R (0.53) GLP1RCALCRCRHR1CRHR2
SCHEMBL30436811 0.87 GLP1R (0.56) GLP1RCALCRCRHR1CRHR2
SCHEMBL30525424 0.87 GRPR (0.47) GLP1RCALCRCRHR1CRHR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback